Ian Garland
Chief Executive Officer
Pharmaceuticals
vernalis
United States of America
Biography
Ian Garland was appointed as Chief Executive Officer on 29 December 2008. From May 2007 until September 2008, Ian was CEO of Acambis plc. During this period Ian oversaw a series of important advances culminating in Acambis’ acquisition by Sanofi-Aventis in September 2008 for £280 million. From 2004 to 2007, Ian served as CFO of Arrow Therapeutics Ltd, a privately held company engaged in the discovery and development of new anti-viral agents until its acquisition by AstraZeneca plc for US$150 million in February 2007.
Research Interest
Prior to this Ian was President and Chief Operating Officer of Celltech Pharmaceuticals Inc., which had a turnover of around US$300 million encompassing the US operations of Celltech Group plc. From 1988 to 1995, Ian worked at KPMG, specialising in the pharmaceutical sector, following qualification as a Chartered Accountant.
